Abbott Laboratories (NYSE: ABT) and Dexcom (NASDAQ: DXCM) are two leading medical device companies that compete against one ...
An SEC filing reveals Uber holds 37.7 million Lucid shares — an 11.5% stake — as its robotaxi commitment expands to 35,000 ...
Osirus AI today announced the public launch of its enterprise AI platform, built from the ground up by three founders with no outside funding. The platform combines every major AI capability — Chat, ...
The blockade of the Strait of Hormuz has delivered a direct and material external shock to Southeast Asia’s energy supply ...
The German defense supplier VINCORION enters a critical phase of its public market life this week. On April 23, the dual safety nets established during its March IPO—the greenshoe option and the ...
The U.S. Navy is accelerating its push into directed energy weapons as drone threats ...
Our hands-on Soundcore Space 2 headphones review finds incredible value in cans with great sound, supreme comfort and robust ...
A string of ASX-listed drug developers is due to release company-making – or breaking – pivotal clinical study results in ...